[EN] NOVEL ESTROGEN RECEPTOR LIGANDS<br/>[FR] NOUVEAUX LIGANDS POUR RÉCEPTEURS D'OESTROGÈNES
申请人:KAROBIO AB
公开号:WO2013017654A1
公开(公告)日:2013-02-07
Compounds of formula (I) or a pharmaceutically acceptable ester, amide, carbamate or salt thereof, including a salt of such an ester, amide or carbamate in which R1 to R9 have meanings as defined in the Specification, are useful as estrogen receptor ligands.
The structure–activity relationship of the unusual indolosesquiterpenoid mycoleptodiscin A is unknown due to natural scarcity and inefficient synthesis. A modular approach leveraging Larock indole synthesis has been established to access mycoleptodiscin A and a divergent collection of drimenyl indoles. It features the utilization of an inexpensive (+)-sclareolide, modularity, purification-economy,
由于自然稀缺性和合成效率低下,不常见的吲哚半萜类霉霉盘素 A 的结构-活性关系尚不清楚。已经建立了利用 Larock 吲哚合成的模块化方法来获取支菌素 A 和不同的连苯酰吲哚集合。它的特点是利用廉价的 (+)-香紫苏内酯、模块化、纯化经济性和可扩展性,这有助于对支菌素 A 和相关前体的首次生物学评估。
US9586891B2
申请人:——
公开号:US9586891B2
公开(公告)日:2017-03-07
NOVEL ESTROGEN RECEPTOR LIGANDS
申请人:KARO BIO AB
公开号:US20140323518A1
公开(公告)日:2014-10-30
Compounds of formula (I) or a pharmaceutically acceptable ester, amide, carbamate or salt thereof, including a salt of such an ester, amide or carbamate in which R
1
to R
9
have meanings as defined in the Specification, are useful as estrogen receptor ligands.